ReviewMolecules (Basel, Switzerland)2025
Recent Advances in
Lu Li, Yongjie Zhu, Haixia Deng, Liqiong Xie, Chang-Bo Zheng, Jian-Neng Yao, Ji Li
Abstract readReview
In one paragraphReview in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Lu LiSchool of Pharmaceutical Sciences and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming 650500, China.
Yongjie ZhuSchool of Pharmaceutical Sciences and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming 650500, China.
Haixia DengSchool of Pharmaceutical Sciences and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming 650500, China.
Liqiong XieSchool of Pharmaceutical Sciences and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming 650500, China.
Chang-Bo ZhengSchool of Pharmaceutical Sciences and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming 650500, China.ORCID 0000-0001-6981-0210 Jian-Neng YaoSchool of Pharmaceutical Sciences and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming 650500, China.ORCID 0000-0002-5844-3352 Ji LiSchool of Pharmaceutical Sciences and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming 650500, China.
Funding
2024 Yunnan Xingdian Talent-Young Talent Support Program to Ji LiFirst-Class Discipline Team of Kunming Medical University 2024XKTDTS12, 2024XKTDPY12National Natural Science Foundation of China 82504612Yunnan Fundamental Research Kunming Medical University Projects 202501AY070001-146Yunnan Fundamental Research Projects 202301AU070135Yunnan Key Research and Development Program 202403AC100033
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
AbietanesBiological ProductsHumansMolecular StructureAbietanesBiological Productsbiological activitiesent-abietane diterpenoidisolationnatural productsstructure elucidationtotal synthesis
Identifiers
PMID41515395
PMCPMC12786761
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390